47 reports

Drug to Agonize Adenosine A## Receptor f or Atrial Fibrillation and Stable Angina Pectoris

  • Angina
  • World
  • Jiangsu
  • Hospital Discharge

Drug to Agonize Adenosine A## Receptor for Atrial Fibrillation and Stable Angina Pectoris

  • Angina
  • World
  • Jiangsu
  • Surgical Procedures Performed

## Angina Pectoris: Executive Summary

  • Angina
  • United States
  • World
  • Smoking Prevalence
  • Mortality Rate

Abstract: - Global Angina Pectoris Drugs Market to Reach $14.3 Billion by 2027 - Amid the COVID-19 crisis, the global market for Angina Pectoris Drugs estimated at US$10 Billion in the year 2020, is projected to reach a revised size of US$14.3 Billion by 2027, growing at a CAGR of 5.3% over the analysis period 2020-2027....

  • Angina
  • Calcium Channel Blocker
  • World
  • China
  • United States

Angina Pectoris Drugs Market Report Overview Angina Pectoris Drugs market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Angina Pectoris Drugs market types and applications. It is a focused study on Angina Pectoris Drugs market space including...

  • Angina
  • World
  • Health Provider Density

‘Refractory Angina (RA) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Refractory Angina epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Refractory Angina (RA) Understanding Refractory...

  • Angina
  • United States
  • Spain
  • France
  • Japan
  • Germany
  • Italy
  • United Kingdom
  • Surgical Procedures Performed

"Angina - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020" report offers comprehensive insights on marketed and Phase III products for Angina. The marketed products information covers their product details, patents (US & EU), historical and forecasted sales till 2023. It further provides the marketed products API manufacturer...

  • Angina
  • World
  • United States
  • Health Expenditure

Refractory Angina (Cardiovascular) - Drugs in Development, 2021 Summary Refractory Angina (Cardiovascular) - Drugs in Development, 2021 provides an overview of the Refractory Angina pipeline landscape. The report provides comprehensive information on the therapeutics under development for...

  • Angina
  • Cardiology
  • Therapy
  • Research And Development
  • World

The global demand for Angina (Angina Pectoris) treatment options is emerging rapidly driven by consumption in major emerging markets. As more growth opportunities will turn up over the medium to long term future, a large number of companies are working on Angina (Angina Pectoris) pipeline. Companies quickly adapting to the change and moving...

  • Angina
  • World
  • Number Of Enterprises

The ongoing clinical trial research report- “2019 Refractory Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Refractory Angina trials across the world. The report presents top level analysis of global Refractory Angina clinical trials across countries, companies and universities. It is designed to provide...

  • Clinical Trial
  • Angina
  • World
  • APAC

The ongoing clinical trial research report- “2019 Stable Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Stable Angina trials across the world. The report presents top level analysis of global Stable Angina clinical trials across countries, companies and universities. It is designed to provide clear understanding...

  • Angina
  • Clinical Trial
  • World
  • APAC

The ongoing clinical trial research report- “2019 Unstable Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Unstable Angina trials across the world. The report presents top level analysis of global Unstable Angina clinical trials across countries, companies and universities. It is designed to provide clear...

  • Angina
  • Clinical Trial
  • World
  • APAC

The ongoing clinical trial research report- “2019 Vasospastic Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Vasospastic Angina trials across the world. The report presents top level analysis of global Vasospastic Angina clinical trials across countries, companies and universities. It is designed to provide...

  • Clinical Trial
  • Angina
  • World
  • APAC

The ongoing clinical trial research report- “2019 Chronic Stable Angina Ongoing Clinical Trials Study” analyzes the current scenario of all active Chronic Stable Angina trials across the world. The report presents top level analysis of global Chronic Stable Angina clinical trials across countries, companies and universities. It is designed...

  • Angina
  • Clinical Trial
  • World
  • APAC

Comprehensive Pipeline Review on Ongoing Clinical and Pre-clinical studies Angina (Angina Pectoris) Drug Development Pipeline Study is the latest publication from VPA Research with comprehensive information of Angina (Angina Pectoris) pipeline products. The Angina (Angina Pectoris) pipeline guide presents complete overview of...

  • Angina
  • World

High levels of pipeline activity are being observed in Angina (Angina Pectoris) treatment during 2019. Clinical development activities are being undertaken by more than 10 companies including Angionetics Inc, Beijing CoSci Med-Tech Co.,Ltd, Caladrius Biosciences Inc, G. Pohl-Boskamp GmbH & Co KG , Hemostemix Inc and others. A Significant...

  • Angina
  • World
  • Drug Approval

2020 Angina (Angina Pectoris) PIPELINE HIGHLIGHTS Angina (Angina Pectoris) is one of the widely researched conditions during 2020 with 9 companies actively focusing on realizing pipeline’s potential. Development of Angina (Angina Pectoris) medicines is identified as integral to the strategy of the majority of companies...

  • Angina
  • World
  • Number Of Enterprises

“Angina pectoris - Pipeline Insight, 2021,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Angina pectoris pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Angina
  • World

“Refractory Angina - Pipeline Insight, 2021,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Refractory Angina pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration,...

  • Angina
  • World
  • Surgical Procedures Performed

TOP-LINE PREVALENCE FOR ANGINA PECTORIS

  • Angina
  • China
  • United States
  • South Korea
  • United Kingdom
  • India
  • Turkey
  • Italy
  • Mexico
  • Canada
  • Spain
  • France
  • Germany
  • Russia
  • Brazil
  • Poland
  • Japan
  • Argentina
  • Australia
  • Netherlands
  • Ireland
  • Chronic Disease Prevalence
  • Urban Population

“Angina (Angina Pectoris) – Pipeline Insight, 2019” report outlays comprehensive insights of present scenario and growth prospects across Angina (Angina Pectoris). A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of...

  • Angina
  • World

The global clinical trial report- “2019 Stable Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Stable Angina. It presents in-depth analysis of Stable Angina clinical trials across markets and companies. The research work is for providing complete understanding into trends in Stable Angina. The...

  • Angina
  • Clinical Trial
  • World

The global clinical trial report- “2019 Refractory Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Refractory Angina. It presents in-depth analysis of Refractory Angina clinical trials across markets and companies. The research work is for providing complete understanding into trends in Refractory...

  • Clinical Trial
  • Angina
  • World

The global clinical trial report- “2019 Unstable Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Unstable Angina. It presents in-depth analysis of Unstable Angina clinical trials across markets and companies. The research work is for providing complete understanding into trends in Unstable...

  • Angina
  • Clinical Trial
  • World

The global clinical trial report- “2019 Vasospastic Angina Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Vasospastic Angina. It presents in-depth analysis of Vasospastic Angina clinical trials across markets and companies. The research work is for providing complete understanding into trends in...

  • Clinical Trial
  • Angina
  • World

“Chronic Stable Angina – Pipeline Insight, 2019” report outlays comprehensive insights of present scenario and growth prospects across Chronic Stable Angina. A detailed picture of the pipeline landscape is provided with summation of data from multiple sources with complete analysis by development stage, mechanism of action, route of administration...

  • Angina
  • World

The global isosorbide market grew at a CAGR of around 9% during 2014-2019. Also known as D-Isosorbide dinitrate, isosorbide (C6H10O4) is a bio-product obtained from starch. The derivatives of isosorbide, namely isosorbide dinitrate and isosorbide mononitrate, find extensive applications across various end use industries...

  • Drug Delivery
  • Recycling
  • Bioproduct
  • Angina
  • Orthopedic Accessory
  • Epoxy Resin
  • Automotive
  • Fossil Fuel
  • World

Figure ##: Mechanisms of the Various Angina Types

  • Angina
  • United States
  • Japan
  • World
  • Smoking Prevalence
  • Overweight Prevalence

Angina Pectoris Drugs Market Analysis, By Therapeutic Class (Beta Blockers, Calcium Antagonists, Nitrates, Anticoagulants, ACE inhibitors, Ranolazine), By Major Markets, And Segment Forecasts, 2016 - 2022 The global angina pectoris drugs market is expected to be valued at USD 10.6 Billion by 2022, as per a new report by Grand...

  • Angina
  • United States

Angina or Angina Pectoris market is estimated to be valued around $12 billion. It occurs when the blood flowing into coronary arteries fails to provide the required oxygen volumes. The main cause of this condition is Coronary heart disease. Unlike heart attack, Angina is temporary and does not cause any damage to the heart muscles. It is often...

  • Angina